| pioglitazone / Generic mfg. |
NCT00835120: Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance |
|
|
| Completed | 4 | 34 | US | Pioglitazone, Actos | University Hospitals Cleveland Medical Center, National Alliance for Research on Schizophrenia and Depression, Takeda Pharmaceuticals North America, Inc. | Metabolic Syndrome, Bipolar Depression, Insulin Resistance | 04/13 | 04/13 | | |
| Completed | 4 | 37 | US | Pioglitazone, Actos, Sugar Pill, Placebo | Stanford University, National Institutes of Health (NIH), National Institute of Mental Health (NIMH) | Major Depressive Disorder, Insulin Resistance | 01/14 | 06/14 | | |
NCT01717040: Pioglitazone for the Treatment of Bipolar Depression |
|
|
| Terminated | 4 | 37 | US | Pioglitazone, Actos, Placebo, Sugar Pill | University Hospitals Cleveland Medical Center, The Depressive and Bipolar Disorder Alternative Treatment Foundation | Bipolar Disorder, Insulin Resistance | 03/16 | 03/16 | | |
